19 Apr, 2026

The second patient dies after obtaining Duchenne’s gene therapy in Sarepta

Andrew Joseph covers health, medicine and biopharmal industry in Europe. You can reach Andrew on signal in Drewqjoseph.45. Sarepta Therapeutics said on Sunday that it interrupted the expeditions of its gene therapy of Duchenne muscular dystrophy for patients who can no longer walk, after the death of a second person who received the treatment. Sarepta […]

1 min read